Suppr超能文献

链脲佐菌素诱导的糖尿病大鼠肾脏中的组胺含量增加。

Renal histamine increases in the streptozotocin-diabetic rat.

作者信息

Markle R A, Hollis T M, Cosgarea A J

出版信息

Exp Mol Pathol. 1986 Feb;44(1):21-8. doi: 10.1016/0014-4800(86)90030-4.

Abstract

Renal histamine concentration, total histamine and protein contents were measured in rats made diabetic via iv streptozotocin injection and held for 13 weeks following diagnosis of diabetes. Insulin (7 U/day) or alpha-hydrazinohistidine (alpha-HH, 25 mg/kg/day) or both drugs were administered to diabetic subgroups the last 2 weeks of the holding period. Untreated diabetics developed significant increases of renal histamine concentration and total histamine content, up 45 and 46%, respectively. Drug interventions reduced the diabetic increases of histamine concentration and content (in order) as follows: diabetic-insulin, down 7 and 8%; diabetic-alpha-HH down 25 and 26%; diabetic-insulin + alpha-HH, down 35 and 36%. Renal tissue protein content was unchanged and qualitative proteinuria was present in all diabetic subgroups. The data indicate that in experimental diabetes there is an increase of the renal inducible histamine pool which is partially reduced by insulin and/or alpha-HH treatments. In view of the long-recognized actions of histamine upon microvascular permeability, elevated renal histamine may be one pathophysiological mediator of the diabetic functional renal microangiopathy manifest as proteinuria.

摘要

通过静脉注射链脲佐菌素使大鼠患糖尿病,并在糖尿病诊断后维持13周,然后测定其肾脏组胺浓度、总组胺含量和蛋白质含量。在维持期的最后2周,对糖尿病亚组给予胰岛素(7 U/天)或α-肼基组氨酸(α-HH,25 mg/kg/天)或两种药物。未经治疗的糖尿病大鼠肾脏组胺浓度和总组胺含量显著增加,分别上升45%和46%。药物干预按以下顺序降低了糖尿病大鼠组胺浓度和含量的增加:糖尿病-胰岛素组,分别下降7%和8%;糖尿病-α-HH组,下降25%和26%;糖尿病-胰岛素+α-HH组,下降35%和36%。所有糖尿病亚组的肾脏组织蛋白质含量均未改变,但存在定性蛋白尿。数据表明,在实验性糖尿病中,肾脏诱导性组胺池增加,胰岛素和/或α-HH治疗可部分降低该组胺池。鉴于组胺对微血管通透性的作用早已为人所知,肾脏组胺升高可能是糖尿病功能性肾微血管病变表现为蛋白尿的一种病理生理介质。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验